Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:2706-2712
Published online before print June 5, 2006, doi: 10.1161/CIRCULATIONAHA.105.606624
CLINICAL PERSPECTIVE
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
113/23/2706    most recent
CIRCULATIONAHA.105.606624v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ades, P. A.
Right arrow Articles by Keteyian, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ades, P. A.
Right arrow Articles by Keteyian, S. J.
Related Collections
Right arrow Secondary prevention
Right arrow Exercise testing
Right arrow Exercise/exercise testing/rehabilitation
Right arrow CV surgery: coronary artery disease
Right arrow Acute myocardial infarction

(Circulation. 2006;113:2706-2712.)
© 2006 American Heart Association, Inc.


Exercise Physiology

Aerobic Capacity in Patients Entering Cardiac Rehabilitation

Philip A. Ades, MD; Patrick D. Savage, MS; Clinton A. Brawner, BS; Caroline E. Lyon, MD; Jonathan K. Ehrman, PhD; Janice Y. Bunn, PhD; Steven J. Keteyian, PhD

From the Divisions of Cardiology (P.A.A., P.D.S., C.E.L.) and Medical Biostatistics (J.Y.B.), University of Vermont College of Medicine, Fletcher-Allen Health Care, Burlington, and Division of Cardiovascular Medicine (C.A.B.), Henry Ford Hospital, Detroit, Mich.

Correspondence to Philip A. Ades, MD, McClure 1, Cardiology, University of Vermont College of Medicine, Burlington, VT 05401. E-mail philip.ades{at}vtmednet.org

Received December 8, 2005; revision received April 3, 2006; accepted April 18, 2006.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background— Symptom-limited treadmill testing is commonly performed on entry to cardiac rehabilitation (CR) for its prognostic value and to design a safe and effective exercise program. Normative values for this evaluation are not available. The primary goals of this study were to establish normative values for peak aerobic capacity (peak VO2) for patients entering CR and to create nomograms for conversion of peak VO2 to a percentage of predicted exercise capacity, stratified by age, gender, and diagnosis.

Methods and Results— Peak VO2 was measured in 2896 patients entering CR from 1996 to 2004. Peak VO2 was higher in men than in women: 19.3±6.1 mL · kg–1 · min–1 (range, 5.2 to 49.7 mL · kg–1 · min–1) versus 14.5±3.9 mL · kg–1 · min–1 (range, 3.8 to 29.8 mL · kg–1 · min–1) (P<0.0001). Peak VO2 decreased steadily with age with a greater rate of decline in men than women (–0.242 versus –0.116 mL · kg–1 · min–1 per year) (P<0.01). Factors associated with lower peak VO2 include coronary artery bypass grafting (CABG), angina at stress testing, hypertension, and, in women, ß-blocking medications. Nomograms are presented for individual values to be compared with mean values by age, gender, and cardiac diagnosis. These include a nomogram to convert estimated maximal metabolic equivalents to actual peak VO2 for patients who do not undergo direct measurement of peak VO2.

Conclusions— Values of peak VO2 on entry to CR are extremely low, particularly in women, approaching values seen with severe chronic heart failure. This underscores the importance of CR after a major cardiac event to improve physical function and long-term prognosis.


Key Words: aerobic capacity • cardiac rehabilitation • exercise • exercise test


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Symptom-limited exercise testing commonly is performed on entry into cardiac rehabilitation (CR) after a major cardiac event. During this evaluation, maximal exercise aerobic capacity (peak VO2) is frequently measured directly, although it is more commonly estimated indirectly from the maximal treadmill workload. Peak VO2 carries important prognostic information for patients with coronary heart disease and chronic heart failure.1–5 It also is used to help formulate a safe, effective, and individualized exercise prescription in CR and to guide return to work and daily activity recommendations. However, despite the almost universal performance of a stress test preceding CR, normative values for peak VO2 on the treadmill in patients with newly diagnosed coronary heart disease have not been established. The determination of normative values for this group of patients is of value beyond the prediction of prognosis; it allows assessment of clinical status of the individual patient compared with peers, leads to the formulation of realistic clinical goals, may provide motivation for patients to participate in CR exercise training, and allows benchmarking of the fitness of patients entering CR compared with established norms. Thus, the primary goals of this study are 2-fold: to establish normative values of peak VO2 for patients entering CR stratified by age, gender, and diagnosis and to create nomograms to allow conversion of measured or estimated peak VO2 data for an individual patient to a percentage of predicted exercise capacity. We also provide data on the exercise training response in a subset of these patients.

Clinical Perspective p 2712


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Study Population
A total of 2896 patients with a recent acute cardiac event requiring hospitalization were evaluated with symptom-limited treadmill testing and expired gas analysis on entry into CR in Burlington, Vt (n=1502), and Detroit, Mich (n=1394), from January 1996 to December 2004. Patient diagnosis was determined from the recent hospital admission that resulted in referral to CR. If >1 cardiac diagnosis was recorded during that admission, we defined the index diagnosis as follows: CABG (n=1166) superceded other reasons for hospitalization such as unstable angina or myocardial infarction (MI). If the admitting diagnosis was MI (n=1064) and a subsequent percutaneous coronary intervention (PCI) was or was not performed, it was coded as an MI. If a PCI was performed in the absence of MI, it was coded as PCI without MI (n=471). Medical therapy for unstable angina was coded as Med Rx (n=190). Other (n=42; 1%) included primarily patients who had undergone surgical heart valve replacement or repair. Cardiac risk factors were determined by patient history for hypertension and smoking and by direct measurement of height and weight for body mass index (BMI in kg/m2) for determination of overweight or obesity. Diabetes mellitus was diagnosed by self-report, fasting glucose measure, an updated problem list, or use of hypoglycemic medications.

Exercise Testing
All patients entering CR at both institutions perform baseline exercise tolerance tests with expired gas analysis. Patients performed a progressive treadmill test until subjective exhaustion, progressive angina, or other untoward findings that would necessitate termination such as ST-segment depression ≥2 mm, symptomatic hypotension (>10 mm Hg below resting systolic blood pressure), hypertension (systolic ≥230 mm Hg, diastolic ≥110 mm Hg), or a sustained supraventricular or ventricular tachyarrhythmia consistent with published guidelines.6,7 All tests were supervised directly by a physician or a doctorally trained exercise physiologist with nearby medical coverage. The exercise testing at both centers used a modified Balke protocol,8 with patients exercising until exhaustion unless an untoward response occurred. Patients took their usual medications the day of the test. Estimated peak heart rates, or "target" heart rates, were not used as a predetermined end point.

Expired gas was continuously collected with a tightly fitted mouthpiece and analyzed during the exercise test. Gas samples were analyzed with a Sensormedics Vmax 29C metabolic cart (Yorba Linda, Calif) at Fletcher-Allen Health Care in Burlington and a Medical Graphics CPX (Minneapolis, Minn) at Henry Ford Hospital in Detroit. The oxygen and carbon dioxide sensors were calibrated immediately before each test with known concentrations of oxygen, nitrogen, and carbon dioxide, and the flow sensors were calibrated with a 3-L syringe. Peak exercise data were averaged over the last 15- to 30-second interval during the final minute of exercise. Peak VO2 and respiratory exchange ratio (ratio of carbon dioxide production to oxygen consumption) were measured at peak exercise. Peak VO2 was expressed relative to body weight (mL · kg–1 · min–1). Peak exercise capacity in estimated maximal metabolic equivalents (METS) was calculated from peak exercise workload in miles per hour and percent elevation through the use of conversions from the American College of Sports Medicine.9 Conversion of measured peak V02 to measured peak METS was performed by dividing measured peak VO2 by 3.5 mL · kg–1 · min–1. Exercise testing was performed a mean of 52±44 days (median, 38 days; 25th percentile, 28 days; 75th percentile, 60 days; minimum, 7 days; maximum, 360 days) after the index cardiac event.

Peak VO2 was measured in a significant subset of patients (n=504 of 1502) from the Vermont site after completion of the 3-month exercise training program. Training data are not presented from the Detroit program because peak VO2 was not systematically measured immediately after exercise training and such data were available for only 5% of participants. The exercise training protocol consisted of 36 hourly sessions of primarily aerobic exercise over a 3-month period, with 25 minutes of treadmill walking per session and 8 minutes each on the arm, cycling, and rowing ergometer. Exercise was performed at an intensity corresponding to 70% to 85% of the maximal heart rate measured at baseline exercise testing with the patient taking usual medications. Reasons for noncompletion of the exercise program included the following: dropping out for lack of interest/motivation (n=253; 17%), incomplete medical insurance coverage (n=234; 16%), returning to full-time work (n=112; 7%), medical problems (n=109; 7%), CR completion but no stress test (n=103; 7%), and (a common reason in the winter months) transfer to another CR program (n=49; 3%). An additional 142 patients (9%) did not complete for undetermined reasons.

Statistical Analysis
Comparisons between groups were based on analysis of variance or analysis of covariance techniques when adjusting for covariates such as age. Categorical variables were compared by use of a {chi}2 test of independence. A value of P<0.05 was considered statistically significant. Regression models were created separately for men and women, as well as for men and women falling into specific diagnostic categories. Solutions to the regression analyses provided the equations used to generate all nomograms. Dependent variables included peak VO2 and percentage of predicted peak VO2, whereas independent variables included age, gender, cardiac diagnosis, and estimated METS. Statistical analyses were performed with Statview and SAS for Windows, version 8.2 (SAS Inc, Cary, NC), whereas nomograms were produced by use of Stata, version 9 (Stata Corp, College Station, Tex). The authors had full access to the data and take responsibility for their integrity. All authors have read and agree to the manuscript as written.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
The combined sample of patients (n=2896) had a mean age of 61±11 years and was 28% female (Table 1). The racial distribution was 71% white, 26% black, and 3% Hispanic or other (Table 2).


View this table:
[in this window]
[in a new window]
 
TABLE 1. Patient Characteristics and Exercise Values


View this table:
[in this window]
[in a new window]
 
TABLE 2. Prevalence of Cardiac Risk Factors, Racial Distribution, and ß-Blocker Use

Peak VO2 was significantly higher in men than in women: 19.3±6.1 mL · kg–1 · min–1 (lowest to highest, 5.2 to 49.7 mL · kg–1 · min–1) versus 14.5±3.9 mL · kg–1 · min–1 (lowest to highest, 3.8 to 29.8 mL · kg–1 · min–1) (P<0.0001). This difference remained after adjustment for age because men were only slightly younger (60.6±11.2 years; range, 21 to 88 years) than the women (62.3±11.4 years; range, 23 to 87 years; P<0.0001). Peak respiratory exchange ratio (VCO2/VO2) was slightly higher in men than in women: 1.11±0.12 versus 1.06±0.03 (P<0.05).

Peak VO2 diminished progressively with age in both men and women from the third through the eighth decade (Figure 1). The rate of decline in men with age (–0.242 mL · kg–1 · min–1 per year) was greater than the rate of decline in women (–0.116 mL · kg–1 · min–1 per year; P<0.01).


Figure 1175750
View larger version (18K):
[in this window]
[in a new window]
 
Figure 1. Unadjusted values for peak aerobic capacity for men and women by decade. Numbers in parentheses are the number of tests per age category in men (dashed line) and women (solid line).

Angina occurred in 5% of tests (150 of 2896) and was associated with a lower peak VO2 in both men (17.6±4.8 versus 19.5±6.2 mL · kg–1 · min–1; P<0.005) and women (13.3±3.3 versus 14.5±4.0 mL · kg–1 · min–1; P<0.05). The presence of ≥1-mm ST-segment depression in the setting of a normal baseline ECG occurred in 9% of tests and had no overall association with peak VO2. Fatigue was the limiting symptom for 86% of stress tests, whereas another 10% of tests were stopped for other symptoms of a cardiovascular nature such as shortness of breath, >2-mm ST-segment depression on the ECG, angina, arrhythmia, hypertension, or hypotension associated with dizziness.

Cardiac diagnostic categories had a significant association with peak VO2 values, even when adjusted for age (Table 3). In men, patients with PCI without MI had the highest values of peak VO2, whereas patients who underwent CABG surgery had the lowest values, with no differences between categories of MI or Med Rx (Table 3). In women, patients with CABG had the lowest values of peak VO2, with no differences between diagnostic categories of MI, Med Rx, or PCI without MI (Table 3). Thus, overall, patients after CABG had significantly lower values of peak VO2 than patients with other cardiac diagnoses.


View this table:
[in this window]
[in a new window]
 
TABLE 3. Peak VO2 by Cardiac Diagnosis

The time elapsed between the day of hospitalization and the day of the exercise test had an association with peak VO2 in that a longer duration before testing was associated with a lower peak VO2. This was due in part to an age effect because longer duration before the stress test correlated with older age (r=0.16, P<0.001). The time since hospitalization differed by diagnosis and gender, with patients after CABG and medically treated angina entering later than patients with MI or PCI without MI (P<0.001). Women in each diagnostic category delayed entry compared with men (Table 4) (P<0.0001).


View this table:
[in this window]
[in a new window]
 
TABLE 4. Entry Diagnoses

The prevalence of cardiac risk factors was 62% for hypertension, 78% for overweight (BMI >25 kg/m2), and 40% for obesity (BMI >30 kg/m2) (Table 2). Smoking within the previous 2 years occurred in 19.4% of patients, whereas 80.6% were smokers in the remote past or never smoked. A recent or past history of smoking had no effect on peak VO2 measured in mL · kg–1 · min–1, although absolute peak VO2 (in L/min) in those who had smoked was lower compared with those who never smoked. The presence of hypertension was associated with a lower age-adjusted peak VO2 in both genders. Peak VO2 also decreased with increasing BMI. Finally, patients with diabetes had lower age-adjusted values of peak VO2 than patients without diabetes (men, 16.7±4.7 versus 20.0±6.3 mL · kg–1 · min–1; P<0.0001; women, 12.9±3.5 versus 15.2±3.6 mL · kg–1 · min–1; P<0.05).

The use of ß-adrenergic blocking medications, taken by 75% of the study sample, was associated in women with a lower peak VO2 (–4%; P=0.03). In men, peak VO2 tended to be lower with ß-blockade (–3%; P=0.056). Race had no effect on peak VO2 regardless of gender.

Nomograms are presented to allow determination of the percentage of predicted peak VO2 for an individual undergoing exercise testing at entry to CR, with gender, age, diagnosis, and measure of peak VO2 known (Figures 2 through 4DownDown). Separate nomograms are presented for the overall male and female samples (Figure 2A), for individuals who have undergone CABG (Figure 3), and for the combined nonsurgical groups of MI, Med Rx of angina, and PCI without MI (Figure 4). Drawing a straight line between age and measured peak VO2 value allows determination of the percentage of predicted peak VO2. For example, in Figure 2A, a value of 120% would result for a patient who is female and 50 years of age who has a peak VO2 of 19 mL · kg–1 · min–1.


Figure 2175750
View larger version (22K):
[in this window]
[in a new window]
 
Figure 2. Combined medical and surgical diagnoses. A, Nomogram for all patients, separated by gender, relating age to measured peak VO2 measured in mL · kg–1 · min–1, giving the percent of predicted value. Regression equation for predicted peak VO2 for men is as follows: 33.970–0.242xage. For women, it is the following: 21.693–0.116xage. Drawing a straight line between age and measured peak VO2 allow determination of the percentage of predicted peak VO2. B, Scatter plot of raw data with r values in women (left) and men (right).


Figure 3175750
View larger version (14K):
[in this window]
[in a new window]
 
Figure 3. After coronary bypass surgery. Nomogram for surgically treated patients, separated by gender, relating age to measured peak VO2 measured in mL · kg–1 · min–1, giving the percent of predicted value. Regression equation for predicted peak VO2 for men is as follows: 30.522–0.202xage. For women, it is the following: 20.127–0.102xage. Drawing a straight line between age and measured peak VO2 allows determination of the percentage of predicted peak VO2.


Figure 4175750
View larger version (14K):
[in this window]
[in a new window]
 
Figure 4. Nomogram for nonsurgically treated patients (MI, Med Rx, and PCI without MI), separated by gender, relating age to measured peak VO2 measured in mL · kg–1 · min–1, giving the percent of predicted value. Regression equation for predicted peak VO2 for men is the following: 35.378–0.252xage. For women, it is as follows: 22.019–0.117xage. Drawing a straight line between age and measured peak VO2 allows determination of the percentage of predicted peak VO2.

A nomogram (Figure 5) also is presented to allow conversion of estimated peak METS to peak VO2 so that, in a setting where expired gas analysis is not performed, peak VO2 can be estimated, allowing use of the previously described nomograms (Figures 2 through 4UpUp) to compare a given patient with normative values. It is noted that estimated peak METS, calculated from the speed and height of the treadmill using the American College of Sports Medicine Equation 9, systematically overestimated peak METS (peak METS=peak VO2/ 3.5). In men, the mean overestimation was by a ratio of 1.30±0.56 (30%); in women, the overestimation was by a ratio of 1.23±0.40 (23%), with the nomogram correcting for these overestimations. The correlation coefficient between estimated peak METS and measured peak METS (measured METS=peak VO2/3.5) was R=0.48 overall (P<0.0001). This correlation was higher in women (R=0.66) than in men (R=0.39; both P<0.001; Figure 5B).


Figure 5175750
View larger version (22K):
[in this window]
[in a new window]
 
Figure 5. A, Nomogram for conversion of estimated peak METS to peak VO2 (in mL · kg–1 · min–1) separated by gender. Internal lines on the y2 axis give the predicted measured peak VO2. Regression equation for predicted peak VO2 in men is as follows: 26.89–0.20xage+0.66xestimated METS. For women, it is the following: 10.15–0.02xage+1.11xestimated METS. Drawing a straight line between age and the estimated peak METS value allows determination of the measured peak VO2. B, Scatter plot of raw data with r values in women (left) and men (right).

Peak VO2 was remeasured in 504 patients after they completed 36 sessions of aerobic training over 3 months at the Vermont study site. Peak VO2 increased overall by 17.0% compared with baseline values (18.3±5.9 to 21.4±6.8 mL · kg–1 · min–1; P<0.0001). The training-induced increase in peak VO2 in men (18%) (n=386) was greater than that seen in women (12%) (n=118) (3.5±4.2 versus 1.8±2.9 mL · kg–1 · min–1; P<0.0001 between groups; both P<0.0001 within groups). Patients not completing the training program had a slightly higher peak VO2 at baseline than those who completed the program (19.4±6.9 versus 18.3±5.9; P<0.01). This was explained primarily by the lower age of noncompleters (60±10 versus 65±10 years; P<0.001).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
Symptom-limited exercise testing with measurement of peak VO2 is commonly performed on entry into CR for several reasons: It provides important prognostic information; it documents the safety of exercise; it assists with return to work guidelines; and it is used to formulate a safe, effective, and individualized exercise prescription for exercise training. Peak VO2 is either directly measured during the exercise test or estimated from the maximal exercise capacity in METS. Despite the routine measure of exercise capacity before CR, normative values are not available for peak VO2 measured on the treadmill. Values cannot be predicted from existing nomograms of exercise tolerance in patients with chronic coronary heart disease10,11 because of the potentially disabling effects of the acute coronary event such as MI or CABG, along with the deconditioning effects of the recovery period, which can last many weeks. Thus, the value of this investigation is that we provide normative values and predictive nomograms for peak VO2 soon after the acute coronary event in patients entering CR. Because many CR programs do not directly measure peak VO2 at the entry stress test but rather estimate peak exercise capacity in METS, we also provide a nomogram for conversion of peak estimated METS to measured peak VO2 so that the data of these patients can be compared with the normative values for peak VO2. Using these data, the clinician can now assess the fitness status of an individual patient in relation to age-, gender-, and diagnoses-matched peers. This will assist not only in estimating prognosis but also in setting realistic clinical goals, in encouraging participation in CR training programs, and in benchmarking fitness levels of patients in a given CR program compared with established norms.

We note that estimating peak workload in METS from the treadmill speed and elevation results in a systematic overestimation of peak METS of 30% in men and 23% in women compared with the direct measurement of peak VO2 and calculation of peak METS. This is clinically relevant because many health insurance companies base the number of approved CR sessions on the baseline functional status of the patient measured in METS, with more sessions covered for less fit patients. Use of our conversion nomogram to peak VO2 and therefore peak METS corrects the overestimation of METS using the American College of Sports Medicine Equation 9, which was not developed or validated in patients with coronary heart disease entering CR and may result in more appropriate insurance coverage for these patients.

Values of peak VO2, particularly for women, were extremely low (overall mean for women, mL · kg–1 · min–1) and approach values seen when patients are considered for cardiac transplantation in the setting of chronic heart failure. Values measured in men, with a mean of 19.3±6.1 mL · kg–1 · min–1, also were low at roughly 60% of age-matched norms for healthy individuals without heart disease.12 Several other clinical factors, particularly cardiac diagnosis and the presence of certain cardiac risk factors, also had an influence on peak VO2.

The effect of age on peak VO2 was powerful. In men, peak VO2 decreased 39% from men in their 40s to men in their 80s. Sequentially, by decade, from 40 to 50 years of age, 50 to 60 years of age, and so on through the 80s, peak VO2 dropped steadily by 11%, 11%, 14%, and 11%, respectively, or –0.242 mL · kg–1 · min–1 per year. The relative drop with age in women was less steep, decreasing by 22% from 40 years of age through the 80s (P<0.01 versus men). From age 40 to 50 years of age, 50 to 60 years of age, and on through the 80s, the decreases were –1%, 7%, 10%, and 8% per decade (P<0.01) or –0.166 mL · kg–1 · min–1 per year (P<0.01 versus men). These age effects are different from the longitudinal data of Fleg et al12 in healthy individuals, which showed an accelerating rate of decline of peak VO2 in the sixth and seventh decades (>20% per decade) compared with the third and fourth decades (3% to 6% per decade). This may be due in part to selective participation in CR where more disabled patients may be less likely to participate. Fleg et al also noted, as did we, that the decline of peak VO2 in women was less steep than in men and that younger women started at a lower level of fitness than younger men.

In our cohort, the impact of cardiac diagnosis on peak VO2 was significant. At all ages and in both men and women, patients who underwent CABG surgery had lower age-adjusted values of peak VO2 than patients treated medically or with a PCI. This is not surprising in that patients undergoing CABG are generally hospitalized longer and require a longer convalescence than patients treated medically. Patients who did not suffer an MI and who underwent PCI had the best exercise tolerance, probably because they had the shortest hospitalizations and had no myocardial damage. Other factors associated with a lower peak VO2 include angina at the stress test, hypertension, diabetes, use of ß-blocking medications, higher BMI, and current or past smoking (absolute VO2 in L/min only for smoking).

Peak VO2 measures in our sample were lower than those seen in other studies of patients entering CR. The studies of Kavanagh et al,2,3 with a younger cohort of patients entering CR between 1968 and 1994 tested on the cycle ergometer showed slightly higher mean values of peak VO2: 20.5 mL · kg–1 · min–1 in men and 15.1 mL · kg–1 · min–1 in women. This was observed despite the fact that peak VO2 measured on the cycle ergometer is lower than that measured on the treadmill.13 Their patients were studied at a time when the mean time until CR entry was {approx}100 days after the cardiac event (ie, a longer recovery period intervened), and the mean age of participants was 53 years in men and 60 years in women compared with our mean ages of 61 years in men and 62 years in women. Although both Kavanagh et al2,3 and Vanhees et al1 documented the prognostic value of the CR entry stress test, neither presented their data in a nomogram, which is a useful format when the results of individual patients are interpreted in the clinical setting. It is notable that despite a mean recovery period of 52 days (median, 38 days) since the cardiac event in the present study, fitness levels were far lower than those measured for age-matched individuals carefully screened to be free of coronary heart disease.12

The extremely low aerobic functional capacities of postcardiac event patients described in this report require that most activities of daily living are performed at a high percentage of an individual’s functional reserve. Thus, many lower-intensity daily activities require a significant level of exertion, likely leading to a reduction of these activities. For example, food shopping while pushing a grocery cart requires a 3.5-MET level of exercise intensity, which, when converted to oxygen consumption, converts to 12.25 mL · kg–1 · min–1, putting the average women in this study at 85% of her maximal aerobic capacity just to go shopping.14 This does not include getting the groceries into the car, to the house, up the stairs, and in cupboards, which can require up to 8 METS, beyond the capacity of most individuals we studied. Avoiding such activities will contribute to a vicious cycle of reduced physical activity and a reduction in functional capacity. This has been confirmed by others who have found extremely high rates of disability in older patients with coronary heart disease.15 CR exercise training and activity counseling are critically important interventions to interrupt this cycle of decline.

Indeed, for the subset of our patients who had peak VO2 measured after 3 months of exercise conditioning, a 17% increase in peak aerobic capacity was measured. This training response is consistent with the relative increases seen in previous studies despite the lower aerobic capacity of the present patients at baseline.16 Thus, despite lower baseline levels of aerobic fitness, the training response to exercise training persists, effectively distancing patients from functional disability. A new finding, however, is the relatively greater increase in peak VO2 seen in male versus female participants (18% versus 12%; P<0.01). Although the women in this study were older than the men, studies have not shown a different relative improvement in peak VO2 response to training by age or gender.17–19

Thus, a strong case is made for the widespread application of CR training protocols, particularly in older coronary patients. In addition to mortality benefits described in both meta-analyses and single-center studies,20–24 the most predictable benefit of CR is an increase in exercise tolerance,16 along with benefits related to physical functioning.25 Selective use of resistance training also has been shown effective in reducing measures of disability in this patient population26,27 and may be associated with increases in peak VO2, although this is controversial.28 Finally, it should be noted that the magnitude of training-induced increases in peak VO2 has been shown to independently predict a decrease in cardiovascular mortality.29

From a clinical point of view, the data collected in this study are useful for the care of individual patients. Patients with lower-than-average fitness for their age, gender, and diagnosis may require longer-term exercise training programs that often are facility based. Displaying data of the individual against age-, gender-, and diagnosis-matched data also may provide increased motivation for patients to pursue exercise training and an active lifestyle.

Limitations of this study include the fact that data were collected only from 2 large CR centers serving communities in semirural New England and the urban Midwest, respectively. Although the combined sample was characterized by both racial and urban-rural diversity, the data may not reflect data from smaller centers in other parts of the country. In addition, although we presented data on the effect of cardiac risk factors on peak VO2, we did not have data on comorbidities such as arthritis, peripheral vascular disease, or obstructive lung disease, each of which could negatively affect exercise capacity. Optimally, a comorbidity score could be added as a dependent variable. We also note that the nomogram presented in Figure 5 that converts estimated METS to peak VO2 has not been validated in an independent sample of patients. Finally, the exercise training data that we have presented are limited by the high percentage of patients who did not complete the entire training program for various reasons.

In summary, we performed 2896 treadmill stress tests on entry into CR with expired gas analysis. Our results document that peak VO2 values were far lower than age-matched norms for healthy individuals and lower than previously published values in CR patients.1–3 These findings imply very high levels of physical disability in contemporary populations of cardiac patients who should benefit significantly from participation in CR exercise training protocols. Nomograms are provided to place the results of an individual patient in the context of age-, gender-, and diagnosis-specific norms in an easily accessible format.


*    Acknowledgments
 
Ronald A Thisted, PhD, chairman of the Department of Health Studies at the University of Chicago, graciously assisted in the preparation of nomograms.

Disclosures

None.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Vanhees L, Fagard R, Thijs L, Staessen J, Amery A. Prognostic significance of peak exercise capacity in patients with coronary artery disease. J Am Coll Cardiol. 1994; 23: 358–363.[Abstract]

2. Kavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, Corey P, Shephard RJ. Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation. Circulation. 2002; 106: 666–671.[Abstract/Free Full Text]

3. Kavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, Corey P, Shephard RJ. Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation. J Am Coll Cardiol. 2003; 42: 2139–2143.[Abstract/Free Full Text]

4. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002; 346: 793–801.[Abstract/Free Full Text]

5. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991; 83: 778–786.[Abstract/Free Full Text]

6. Franklin BA, ed. ACSM’s Guidelines for Exercise Testing and Prescription. 6th ed. Baltimore, Md: Williams and Wilkins; 2000.

7. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O’Reilly MG, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, for the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Committee to Update the 1997 Exercise Testing Guidelines. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol. 2002; 40: 1531–1540.[Free Full Text]

8. Froelicher VF Jr, Brammell H, Davis G, Noguera I, Stewart A, Lancaster MC. A comparison of the reproducibility and physiologic response to three maximal treadmill exercise protocols. Chest. 1974; 65: 512–517.[Medline] [Order article via Infotrieve]

9. ACSM Guidelines for Exercise Testing and Prescription. 7th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2005: 286–299.

10. Gulati M, Black HR, Shaw LJ, Arnsdorf MF, Merz CN, Lauer MS, Marwick TH, Pandey DK, Wicklund RH, Thisted RA. The prognostic value of a nomogram for exercise capacity in women. N Engl J Med. 2005; 353: 468–475.[Abstract/Free Full Text]

11. Morris CK, Myers J, Froelicher VF, Kawaguchi T, Ueshima K, Hideg A. Nomogram based on metabolic equivalents and age for assessing aerobic exercise capacity in men. J Am Coll Cardiol. 1993; 22: 175–182.[Abstract]

12. Fleg JL, Morrell CH, Bos AG, Brant LJ, Talbot LA, Wright JG, Lakatta EG. Accelerated longitudinal decline of aerobic capacity in healthy older adults. Circulation. 2005; 112: 674–682.[Abstract/Free Full Text]

13. Hambrecht RP, Schuler GC, Muth T, Grunze MF, Marburger CT, Niebauer J, Methfessel SM, Kubler W. Greater diagnostic sensitivity of treadmill versus cycle exercise testing of asymptomatic men with coronary artery disease. Am J Cardiol. 1992; 70: 141–146.[CrossRef][Medline] [Order article via Infotrieve]

14. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O’Brien WL, Bassett DR Jr, Schmitz KH, Emplaincourt PO, Jacobs DR Jr, Leon AS. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000; 3: S498–S504.[CrossRef]

15. Pinsky JL, Jette AM, Branch LG, Kannel WB, Feinleib M. The Framingham Disability Study: relationship of various coronary heart disease manifestations to disability in older persons living in the community. Am J Public Health. 1990; 80: 1363–1368.[Abstract/Free Full Text]

16. Wenger NK, Froelicher ES, Smith LK, Ades PA, Berra K, Blumenthal JA, Certo CME, Dattilo AM, Davis D, DeBusk RF, Drozda JP, Fletcher BJ, Franklin BA, Gaston H, Greenland P, McBride PE, McGregor CGA, Oldridge NB, Piscatella JC, Rogers FJ. Cardiac Rehabilitation: Clinical Practice Guideline No. 17. Rockville, Md: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research and the National Heart, Lung and Blood Institute. October 1995. AHCPR Publication No. 96–0672.

17. Ades PA, Grunvald MH. Cardiopulmonary exercise testing before and after conditioning in older coronary patients. Am Heart J. 1990; 120: 585–589.[CrossRef][Medline] [Order article via Infotrieve]

18. Cannistra LB, Balady GJ, O’Malley CJ, Weiner DA, Ryan TJ. Comparison of the clinical profile and outcome of women and men in cardiac rehabilitation. Am J Cardiol. 1992; 69: 1274–1279.[CrossRef][Medline] [Order article via Infotrieve]

19. Ades PA, Waldmann ML, Polk DM, Coflesky JT. Referral patterns and exercise response in the rehabilitation of female coronary patients aged greater than or equal to 62 years. Am J Cardiol. 1992; 69: 1422–1425.[CrossRef][Medline] [Order article via Infotrieve]

20. O’Connor GT, Buring JE, Yusuf S, Goldhaber SZ, Olmstead EM, Paffenbarger RS Jr, Hennekens C. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation. 1989; 80: 234–244.[Abstract/Free Full Text]

21. Oldridge NB, Guyatt GH, Fischer ME, Rimm AA. Cardiac rehabilitation after myocardial infarction: combined experience of randomized clinical trials. JAMA. 1988; 260: 945–950.[Abstract/Free Full Text]

22. Jolliffe JA, Rees K, Taylor RS, Thompson D, Oldridge N, Ebrahim S. Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2001: CD001800. DOI:10.1002/14651858.

23. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, Skidmore B, Stone JA, Thompson DR, Oldridge N. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med. 2004; 116: 714–716.[CrossRef][Medline] [Order article via Infotrieve]

24. Witt BJ, Jacobsen SJ, Weston SA, Killian JM, Meverden RA, Allison TG, Reeder GS, Roger VL. Cardiac rehabilitation after myocardial infarction in the community. J Am Coll Cardiol. 2004; 44: 988–996.[Abstract/Free Full Text]

25. Ades PA, Maloney AE, Savage P, Carhart RL Jr. Determinants of physical function in coronary patients: response to cardiac rehabilitation. Arch Intern Med. 1999; 159: 2357–2360.[Abstract/Free Full Text]

26. Brochu M, Savage P, Lee M, Dee J, Cress ME, Poehlman ET, Tischler M, Ades PA. Effects of resistance training on physical function in older disabled women with coronary heart disease. J Appl Physiol. 2002; 92: 672–678.[Abstract/Free Full Text]

27. Ades PA, Savage PD, Cress ME, Brochu M, Lee NM, Poehlman ET. Resistance training improves performance of daily activities in disabled older women with coronary heart disease. Med Sci Sports Exerc. 2003; 8: 1265–1270.

28. Vincent KR, Braith RW, Feldman RA, Kallas HE, Lowenthal DT. Improved cardiorespiratory endurance following 6 months of resistance exercise in elderly men and women. Arch Intern Med. 2002; 162: 673–678.[Abstract/Free Full Text]

29. Vanhees L, Fagard R, Thijs L, Amery A. Prognostic value of training-induced change in peak exercise capacity in patients with myocardial infarcts and patients with coronary bypass surgery. Am J Cardiol. 1995; 76: 1014–1019.[CrossRef][Medline] [Order article via Infotrieve]


 

CLINICAL PERSPECTIVE

In this study of peak VO2 in patients entering cardiac rehabilitation (CR) after a coronary event, we analyzed results in 2896 patients. Peak VO2 in women was particularly low, with values approximating those seen in patients with severe chronic heart failure. Our results affirm the importance of CR exercise training programs for these patients. Along with gender, other factors that predicted low fitness were older age, CABG surgery, the occurrence of angina at the stress test, hypertension, obesity, and type 2 diabetes mellitus. Nomograms are presented to determine for the individual patient the percentage of predicted peak VO2 given the patient’s age, gender, and diagnosis. Results from this study will assist clinicians in estimating prognosis, setting realistic clinical goals, encouraging patient participation in CR exercise, and benchmarking fitness levels against established norms. A nomogram also is presented to convert estimated fitness level in maximal metabolic equivalents to actual peak VO2 for patients who do not undergo direct measurement of peak VO2. This conversion shows that the commonly used conversion equation from the American College of Sports Medicine overestimates fitness levels by 30%. Because baseline exercise capacity is often used by third-party health insurers to determine the number of rehabilitation sessions required, a more accurate determination of exercise capacity may afford a greater number of sessions to the typical patient.




This article has been cited by other articles:


Home page
CirculationHome page
P. A. Ades, P. D. Savage, M. J. Toth, J. Harvey-Berino, D. J. Schneider, J. Y. Bunn, M. C. Audelin, and M. Ludlow
High-Calorie-Expenditure Exercise: A New Approach to Cardiac Rehabilitation for Overweight Coronary Patients
Circulation, May 26, 2009; 119(20): 2671 - 2678.
[Abstract] [Full Text] [PDF]


Home page
Health Educ BehavHome page
N. M. Clark, N. K. Janz, J. A. Dodge, Xihong Lin, B. L. Trabert, N. Kaciroti, L. Mosca, J. R. Wheeler, and S. Keteyian
Heart Disease Management by Women: Does Intervention Format Matter?
Health Educ Behav, April 1, 2009; 36(2): 394 - 409.
[Abstract] [PDF]


Home page
Br. J. Sports. Med.Home page
K Woolf-May and D Ferrett
Metabolic equivalents during the 10-m shuttle walking test for post-myocardial infarction patients
Br. J. Sports Med., January 1, 2008; 42(1): 36 - 41.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. A. Suaya, D. S. Shepard, S.-L. T. Normand, P. A. Ades, J. Prottas, and W. B. Stason
Use of Cardiac Rehabilitation by Medicare Beneficiaries After Myocardial Infarction or Coronary Bypass Surgery
Circulation, October 9, 2007; 116(15): 1653 - 1662.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Arena, J. Myers, M. A. Williams, M. Gulati, P. Kligfield, G. J. Balady, E. Collins, and G. Fletcher
Assessment of Functional Capacity in Clinical and Research Settings: A Scientific Statement From the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing
Circulation, July 17, 2007; 116(3): 329 - 343.
[Full Text] [PDF]


Home page
CirculationHome page
J. H. Newman and I. M. Robbins
Exercise Training in Pulmonary Hypertension: Implications for the Evaluation of Drug Trials
Circulation, October 3, 2006; 114(14): 1448 - 1449.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
113/23/2706    most recent
CIRCULATIONAHA.105.606624v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ades, P. A.
Right arrow Articles by Keteyian, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ades, P. A.
Right arrow Articles by Keteyian, S. J.
Related Collections
Right arrow Secondary prevention
Right arrow Exercise testing
Right arrow Exercise/exercise testing/rehabilitation
Right arrow CV surgery: coronary artery disease
Right arrow Acute myocardial infarction